[ad_1] DOVER, Del., Oct. 22, 2025 /PRNewswire/ — Expert Systems Inc., a leading life sciences accelerator, announced its continued support for Traws Pharma (NASDAQ: TRAW) as the company initiates Phase 2 clinical studies of Ratutrelvir […]